investorscraft@gmail.com

Intrinsic value of Tactile Systems Technology, Inc. (TCMD)

Previous Close$8.91
Intrinsic Value
Upside potential
Previous Close
$8.91

VALUATION INPUT DATA (original, your and others' valuations)

ParameterOrig.Your
Date of valuation (DoV)  
Intrinsic value (IV) at DoV, $/sh  
IV at current val. algorithm, $/sh41.45 

The original valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-03-31.

Registered users can save their valuation input data

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

NOTE: The bar chart shows historic and forecasted yearly revenue growth rates. Its purpose is to help you in determining what initial revenue rate you want to base your stock valuation on. Please make sure that you are confident in the value you select - for most stocks it is by far the most important parameter in valuation.

Company description

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entré System, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and ACTitouch system, a medical device for the treatment of venous leg ulcers chronic venous insufficiency patients. It also provides Airwear Gradient Compression Wrap that is used in the management of venous insufficiency, venous hypertension, venous ulcerations, and lymphedema under the trade name Aero-Wrap. The company was founded in 1995 and is headquartered in Minneapolis, Minnesota.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2021(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %11.2NaN
Revenue, $208NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m210NaN
Operating income, $m-2NaN
EBITDA, $m2NaN
Interest expense (income), $mNaN
Earnings before tax, $m-2NaN
Tax expense, $m10NaN
Net income, $m-12NaN

BALANCE SHEET

Cash and short-term investments, $m28NaN
Total assets, $m244NaN
Adjusted assets (=assets-cash), $m216NaN
Average production assets, $m72NaN
Working capital, $m79NaN
Total debt, $m81NaN
Total liabilities, $m116NaN
Total equity, $m128NaN
Debt-to-equity ratio0.629NaN
Adjusted equity ratio0.488NaN

CASH FLOW

Net income, $m-12NaN
Depreciation, amort., depletion, $m4NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m3NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-2NaN
Free cash flow, $m5NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m79
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount